Nemaura Medical (NMRD) Announces Quarterly Earnings Results

Nemaura Medical (OTCMKTS:NMRD) posted its quarterly earnings data on Monday. The company reported $0.00 EPS for the quarter, Zacks reports.

Shares of OTCMKTS NMRD traded down $0.04 during trading on Wednesday, hitting $1.12. The company had a trading volume of 58,059 shares, compared to its average volume of 138,997. Nemaura Medical has a 12 month low of $0.80 and a 12 month high of $5.80.

TRADEMARK VIOLATION WARNING: This article was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.com-unik.info/2019/02/13/nemaura-medical-nmrd-announces-quarterly-earnings-results.html.

Nemaura Medical Company Profile

Nemaura Medical, Inc is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company’s focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source.

Read More: How does inflation affect different investments?

Earnings History for Nemaura Medical (OTCMKTS:NMRD)

Receive News & Ratings for Nemaura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemaura Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit